{
  "personality": null,
  "timestamp": "2026-02-18T05:36:48.998514",
  "category": "Health",
  "news_summary": "Recent scientific breakthroughs have uncovered hidden cancer mechanisms, identified brain switches that clear Alzheimer's plaques, revealed key factors for heart health from large-scale data, and leveraged social media influencers to combat health misinformation.",
  "news_summary_fr": "Des avancées scientifiques récentes ont permis de découvrir des mécanismes cachés du cancer, d'identifier des commutateurs cérébraux qui éliminent les plaques d'Alzheimer, de révéler des facteurs clés pour la santé cardiaque à partir de données à grande échelle et de tirer parti de l'influence des réseaux sociaux pour lutter contre la désinformation en matière de santé.",
  "news_summary_es": "Los últimos avances científicos han descubierto mecanismos ocultos del cáncer, identificado interruptores cerebrales que eliminan las placas de Alzheimer, revelado factores clave para la salud cardíaca a partir de datos a gran escala y aprovechado la influencia de las redes sociales para combatir la desinformación sobre salud.",
  "articles": [
    {
      "title": "Mysterious RNA led scientists to a hidden layer of cancer",
      "summary": "A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across dozens of tumor types. These molecules form unique molecular signatures that identify cancer type and subtype with remarkable accuracy. Some even drive tumor growth and metastasis. Because many are released into the bloodstream, a simple blood test can track how patients respond to treatment and predict survival.",
      "content": "The journey began with T3p, a small RNA molecule detected in breast cancer but not in normal tissue. When it was first described in 2018, it stood out as unusual. That initial finding launched a six-year effort to systematically identify similar orphan non-coding RNAs (oncRNAs) across major cancer types, determine which ones actively contribute to disease, and test whether they could help monitor patients using simple blood tests.\n\nIn our newly published study, we describe how this work progressed from analyzing large cancer genome datasets to developing machine learning models, conducting large-scale functional experiments in mice, and ultimately confirming the clinical relevance of these RNAs in nearly 200 breast cancer patients using blood samples.\n\nCancer-Specific OncRNAs Are Widespread\n\nOne of the first major discoveries was that this phenomenon was not limited to breast cancer. By examining small RNA sequencing data from The Cancer Genome Atlas across 32 different cancer types, we identified approximately 260,000 cancer-specific small RNAs. We refer to these molecules as oncRNAs, and they were present across every cancer type analyzed.\n\nTheir distribution was not random. Each cancer type displayed its own distinct oncRNA expression pattern. Lung cancers, for example, showed a different set of oncRNAs compared with breast cancers. Using these patterns, machine learning models were able to classify cancer types with 90.9% accuracy. When tested in a separate group of 938 tumors, classification accuracy remained high at 82.1%.\n\nDifferences also emerged within individual cancers. Basal breast tumors showed oncRNA patterns distinct from luminal tumors, suggesting additional subtypes that may not yet be fully defined. These findings indicate that oncRNAs reflect fundamental aspects of cancer cell state. Patterns of oncRNA presence and absence function as \"digital molecular barcodes\" that capture cancer identity at multiple levels, including tumor type, subtype, and cellular state.\n\nSome OncRNAs Actively Drive Tumor Growth\n\nAlthough oncRNAs serve as powerful biomarkers, we also wanted to understand whether some of them directly influence cancer progression. Specifically, we asked whether cancer cells could use these newly emerged RNA molecules to activate oncogenic pathways.\n\nTo test this, we created screening libraries containing about 400 oncRNAs from breast, colon, lung, and prostate tumors. These RNAs were introduced into cancer cells using lentiviral vectors. In half of the cases, we increased oncRNA expression. In the other half, we reduced expression using \"Tough Decoy\" constructs. The modified cells were then implanted into mice to determine which oncRNAs enhanced tumor growth.\n\nRoughly 5% of the oncRNAs produced clear biological effects in xenograft mouse models. Two breast cancer oncRNAs were examined more closely. One triggered epithelial-mesenchymal transition, an essential step in cancer progression and metastasis. The other activated E2F target genes, promoting cell proliferation. Both significantly accelerated tumor growth and increased metastatic colonization in independent cell line models.\n\nWhen we examined patient tumor data, we found that tumors expressing these same oncRNAs displayed similar pathway changes. Observing consistent biological patterns in TCGA samples and experimental models strengthened our confidence in the findings.\n\nCancer Cells Release OncRNAs Into the Bloodstream\n\nPerhaps the most clinically important discovery was that cancer cells actively release many of these oncRNAs into the bloodstream. Tracking these circulating RNAs provides insight into how patients are responding to treatment.\n\nWe analyzed cell-free RNA from 25 cancer cell lines across 9 tissue types and found that about 30% of oncRNAs are actively secreted. To confirm their clinical relevance, we studied serum samples from 192 breast cancer patients enrolled in the I-SPY 2 neoadjuvant chemotherapy trial. Blood samples were collected before and after treatment, and we calculated the change in total oncRNA burden (ΔoncRNA below).\n\nThat single measurement proved highly informative. Patients with high residual oncRNA levels after chemotherapy had nearly 4-fold worse overall survival. This association remained significant even after accounting for standard clinical indicators such as pathologic complete response and residual cancer burden.\n\nThis was our most ambitious goal. Although we knew oncRNAs could be detected in blood, it was uncertain whether they would provide meaningful information in real patient samples. Detecting such a strong signal from just 1 milliliter of serum was unexpected.\n\nA New Approach to Monitoring Minimal Residual Disease\n\nThese findings address a significant clinical challenge. Monitoring minimal residual disease in breast cancer using markers such as cell-free DNA is difficult because tumors often release very little DNA into the bloodstream, particularly in early stages. RNA-based monitoring may offer an advantage because cancer cells actively secrete RNA rather than passively shedding DNA.\n\nWhat Comes Next for OncRNA Research\n\nImportant biological and clinical questions remain. How do functional oncRNAs exert their effects? Do they interact with proteins or with other RNAs? Could tracking oncRNA changes in real time guide treatment decisions? Might they help detect recurrence earlier or improve patient stratification? Answering these questions will require more extensive research and larger prospective clinical trials.\n\nAt the same time, translation is already underway. The discovery that oncRNAs generate cancer-specific signals in blood is moving toward clinical application. We are collaborating with the biotech company Exai Bio (Hani is a co-founder) to develop oncRNA-based diagnostics. The company has been building artificial intelligence models and assembling diverse datasets to improve cancer detection and classification.\n\nTranslational research depends on many contributors. When analyzing tens of thousands of samples computationally, it is easy to forget that each one represents a person who volunteered for research, donated blood, and hoped their participation would help others. Honoring those contributions through careful and rigorous science motivates our entire team.\n\nWe believe oncRNAs represent a newly recognized class of cancer-emergent molecules that function both as drivers of disease and as biomarkers. By making this resource openly available, we hope to accelerate progress and open new avenues of research in cancer biology.",
      "url": "https://www.sciencedaily.com/releases/2026/02/260216084527.htm",
      "source": "Latest Science News -- ScienceDaily",
      "published": "2026-02-17",
      "sentiment_score": 0.9,
      "reasoning": "The article reports a significant scientific breakthrough identifying a new class of cancer-specific RNAs (oncRNAs) that can accurately classify cancer types and subtypes, actively drive tumor growth, and be detected in blood for monitoring treatment response and predicting survival. This discovery has broad implications across many cancer types, offers a new minimally invasive diagnostic tool, and is progressing toward clinical application, representing a meaningful advance in cancer diagnosis and management.",
      "category": "Health",
      "personality_title": "Scientists discover new cancer-specific RNAs that improve diagnosis and treatment monitoring",
      "personality_presentation": "**Context** – Scientists have been searching for better ways to detect and understand cancer. One challenge is finding molecules that are unique to cancer cells and can help track the disease without invasive tests.\n\n**What happened** – Researchers found a new group of small RNA molecules, called oncRNAs, which are present only in cancer cells. They started with one RNA found in breast cancer and expanded their search to 32 types of cancer. Using computer programs, they identified about 260,000 oncRNAs, each cancer type having its own unique pattern. Some of these oncRNAs help tumors grow and spread. Importantly, these RNAs are released into the bloodstream, allowing doctors to monitor cancer through a simple blood test. In a study of nearly 200 breast cancer patients, the level of oncRNAs in blood after chemotherapy helped predict survival chances.\n\n**Impact** – This discovery is unique because oncRNAs act like digital barcodes that identify not only the type of cancer but also its subtype and behavior. Unlike DNA, cancer cells actively send these RNAs into the blood, making it easier to track the disease with a blood test. This could change how doctors monitor cancer treatment and detect if cancer is coming back, especially when traditional methods are less effective.\n\n**What's next step** – Scientists plan to study how oncRNAs work inside cancer cells and whether they interact with other molecules. They also want to test if tracking oncRNAs over time can help doctors make better treatment decisions. Meanwhile, a biotech company is working to develop new blood tests based on oncRNAs to detect and classify cancers more accurately.\n\n**One-sentence takeaway** – A new class of cancer-specific RNAs offers a promising way to identify, track, and understand cancers through simple blood tests, improving diagnosis and treatment monitoring.",
      "personality_title_fr": "Des scientifiques découvrent de nouveaux ARN spécifiques au cancer pour améliorer le diagnostic et le suivi des traitements",
      "personality_presentation_fr": "**Contexte** – Les scientifiques cherchent des moyens plus efficaces de détecter et de comprendre le cancer. Un défi est de trouver des molécules uniques aux cellules cancéreuses qui permettent de suivre la maladie sans tests invasifs.\n\n**Ce qui s’est passé** – Les chercheurs ont découvert un nouveau groupe de petites molécules d’ARN, appelées oncARNs, présentes uniquement dans les cellules cancéreuses. Ils ont commencé avec un ARN trouvé dans le cancer du sein, puis ont élargi leur recherche à 32 types de cancer. Grâce à des programmes informatiques, ils ont identifié environ 260 000 oncARNs, chaque type de cancer ayant un motif unique. Certains oncARNs favorisent la croissance et la propagation des tumeurs. Ces ARN sont aussi libérés dans le sang, ce qui permet aux médecins de suivre le cancer par un simple test sanguin. Dans une étude portant sur près de 200 patientes atteintes de cancer du sein, le niveau d’oncARNs dans le sang après la chimiothérapie a permis de prédire les chances de survie.\n\n**Impact** – Cette découverte est unique car les oncARNs agissent comme des codes-barres numériques qui identifient non seulement le type de cancer, mais aussi son sous-type et son comportement. Contrairement à l’ADN, les cellules cancéreuses envoient activement ces ARN dans le sang, facilitant ainsi le suivi de la maladie par un test sanguin. Cela pourrait changer la manière dont les médecins surveillent le traitement du cancer et détectent une éventuelle récidive, surtout lorsque les méthodes traditionnelles sont moins efficaces.\n\n**Prochaine étape** – Les scientifiques veulent étudier comment les oncARNs fonctionnent à l’intérieur des cellules cancéreuses et s’ils interagissent avec d’autres molécules. Ils souhaitent aussi tester si le suivi des oncARNs dans le temps peut aider les médecins à mieux choisir les traitements. Parallèlement, une entreprise de biotechnologie travaille à développer de nouveaux tests sanguins basés sur les oncARNs pour détecter et classifier les cancers avec plus de précision.\n\n**Une phrase clé** – Une nouvelle classe d’ARN spécifiques au cancer offre un moyen prometteur d’identifier, de suivre et de comprendre les cancers grâce à de simples analyses de sang, améliorant ainsi le diagnostic et le suivi des traitements.",
      "personality_title_es": "Científicos descubren nuevos ARN específicos de cáncer para mejorar el diagnóstico y monitoreo del tratamiento",
      "personality_presentation_es": "**Contexto** – Los científicos buscan mejores formas de detectar y entender el cáncer. Un reto es encontrar moléculas únicas en las células cancerosas que ayuden a seguir la enfermedad sin pruebas invasivas.\n\n**Qué pasó** – Investigadores encontraron un nuevo grupo de pequeñas moléculas de ARN, llamadas oncARNs, que sólo están en células cancerosas. Comenzaron con un ARN hallado en cáncer de mama y ampliaron la búsqueda a 32 tipos de cáncer. Usando programas de computadora, identificaron alrededor de 260,000 oncARNs, cada tipo de cáncer con un patrón único. Algunos oncARNs ayudan a que los tumores crezcan y se propaguen. Lo importante es que estos ARN se liberan en la sangre, permitiendo a los médicos monitorear el cáncer con un simple análisis de sangre. En un estudio con casi 200 pacientes con cáncer de mama, el nivel de oncARNs en la sangre después de la quimioterapia ayudó a predecir la supervivencia.\n\n**Impacto** – Este descubrimiento es único porque los oncARNs funcionan como códigos digitales que identifican no solo el tipo de cáncer, sino también su subtipo y comportamiento. A diferencia del ADN, las células cancerosas envían activamente estos ARN a la sangre, facilitando el seguimiento de la enfermedad con un análisis de sangre. Esto podría cambiar cómo los médicos monitorean el tratamiento y detectan si el cáncer regresa, especialmente cuando los métodos tradicionales son menos efectivos.\n\n**Próximo paso** – Los científicos planean estudiar cómo funcionan los oncARNs dentro de las células cancerosas y si interactúan con otras moléculas. También quieren probar si seguir los oncARNs en el tiempo puede ayudar a los médicos a tomar mejores decisiones de tratamiento. Mientras tanto, una empresa de biotecnología trabaja para desarrollar nuevos análisis de sangre basados en oncARNs para detectar y clasificar cánceres con mayor precisión.\n\n**Una frase clave** – Una nueva clase de ARN específicos del cáncer ofrece una forma prometedora de identificar, seguir y entender los cánceres mediante simples análisis de sangre, mejorando el diagnóstico y el monitoreo del tratamiento.",
      "image_url": "public/images/news_image_Mysterious-RNA-led-scientists-to-a-hidden-layer-of.png",
      "image_prompt": "A detailed, warm painting of a glowing, intricate RNA strand shaped like a delicate key unlocking a softly illuminated hidden chamber filled with layered, colorful molecular patterns symbolizing diverse cancer types, set against a gentle background of flowing blood cells carrying tiny radiant RNA fragments, all rendered in natural, muted tones."
    },
    {
      "title": "Scientists discover brain switches that clear Alzheimer’s plaques",
      "summary": "Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s disease. By stimulating these receptors in mice, scientists increased levels of a natural amyloid-breaking enzyme, reduced buildup in the brain, and improved memory-related behavior. Because these receptors are common drug targets, the findings could open the door to affordable pill-based treatments with fewer side effects.",
      "content": "Scientists at Karolinska Institutet in Sweden and the RIKEN Center for Brain Science in Japan have identified two brain receptors that help regulate the breakdown of amyloid beta, the protein that builds up in Alzheimer's disease. Their findings suggest it may be possible to develop future medications that are both safer and more affordable than today's antibody based treatments.\n\nAlzheimer's disease is the leading cause of dementia and is marked by sticky clumps of amyloid beta (Aβ) forming plaques in the brain. Normally, an enzyme called neprilysin helps clear away Aβ. However, neprilysin activity declines with aging and during the progression of the disease. The research team discovered that two somatostatin receptors, SST1 and SST4, work together to control neprilysin levels in the hippocampus, a region essential for memory. The findings were published in the Journal of Alzheimer's Disease.\n\nBoosting the Brain's Natural Defense System\n\nThe researchers conducted experiments using genetically modified mice and laboratory grown cells. When both SST1 and SST4 receptors were missing, neprilysin levels dropped. As a result, amyloid beta accumulated and the mice showed memory problems.\n\nThe team also tested a compound designed to activate these two receptors. In mice with Alzheimer's-like brain changes, stimulating SST1 and SST4 increased neprilysin levels, reduced amyloid beta buildup, and improved behavior. Importantly, the treatment did not cause serious side effects.\n\n\"Our findings show that the brain's own defence against amyloid beta can be strengthened by stimulating these receptors,\" says Per Nilsson, docent at the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet.\n\nToward Safer and More Affordable Alzheimer's Drugs\n\nMany of the most advanced Alzheimer's therapies currently rely on antibodies. While these treatments can target amyloid, they are extremely expensive and may trigger significant side effects in some patients.\n\n\"If we can instead develop small molecules that pass the blood-brain barrier, our hope is that we will be able to treat the disease at a significantly lower cost and without serious side effects,\" says Per Nilsson.\n\nSST1 and SST4 belong to a large family of proteins known as G protein-coupled receptors. These receptors are common drug targets because they are well understood and often respond to medications that can be produced at lower cost and taken in pill form.\n\nThe project brought together researchers from Karolinska Institutet in Sweden, RIKEN Center for Brain Science in Japan, and several other international universities. Funding was provided by organizations including the Swedish Research Council, the Hållsten Research Foundation, the Alzheimer's Foundation and the private initiative Innovative ways to fight Alzheimer´s disease -- Leif Lundblad Family and others and RIKEN. The researchers report no conflicts of interest.",
      "url": "https://www.sciencedaily.com/releases/2026/02/260215225555.htm",
      "source": "Latest Science News -- ScienceDaily",
      "published": "2026-02-17",
      "sentiment_score": 0.9,
      "reasoning": "The article reports a significant scientific breakthrough identifying brain receptors that regulate the clearance of amyloid beta plaques, a key factor in Alzheimer's disease. This discovery has broad implications for developing safer, more affordable, and effective treatments that could benefit millions affected by Alzheimer's globally. The study is well detailed, focusing on a single impactful topic with clear potential for real-world health improvements.",
      "category": "Health",
      "personality_title": "Scientists find brain receptors that help clear Alzheimer’s plaques",
      "personality_presentation": "**Context** – Alzheimer’s disease causes memory loss and is linked to sticky protein clumps called amyloid beta plaques forming in the brain. Normally, an enzyme called neprilysin helps clean these plaques, but it works less well with age and disease.\n\n**What happened** – Researchers from Sweden and Japan discovered two brain receptors, SST1 and SST4, that control neprilysin levels in the memory-related part of the brain. In experiments with mice, activating these receptors raised neprilysin, reduced plaques, and improved memory behaviors without serious side effects.\n\n**Impact** – This discovery is important because it points to a new way to treat Alzheimer’s using drugs that target these receptors. These drugs could be taken as pills, cost less, and cause fewer side effects than current antibody treatments.\n\n**What's next step** – Scientists will work on developing small molecule drugs that activate SST1 and SST4 in humans. If successful, this could lead to safer, more affordable medicines that help clear plaques and protect memory.\n\n**One-sentence takeaway** – Activating two brain receptors may boost the brain’s natural ability to clear Alzheimer’s plaques, opening the door to better treatments.",
      "personality_title_fr": "Des scientifiques découvrent des récepteurs cérébraux qui éliminent les plaques d'Alzheimer",
      "personality_presentation_fr": "**Contexte** – La maladie d'Alzheimer provoque des pertes de mémoire et est liée à des amas collants de protéines appelés plaques bêta-amyloïdes dans le cerveau. Normalement, une enzyme nommée néprilysine aide à nettoyer ces plaques, mais elle fonctionne moins bien avec l'âge et la maladie.\n\n**Ce qui s'est passé** – Des chercheurs de Suède et du Japon ont découvert deux récepteurs cérébraux, SST1 et SST4, qui contrôlent les niveaux de néprilysine dans la partie du cerveau liée à la mémoire. En activant ces récepteurs chez des souris, ils ont augmenté la néprilysine, réduit les plaques et amélioré la mémoire, sans effets secondaires graves.\n\n**Impact** – Cette découverte est importante car elle ouvre la voie à un nouveau traitement de la maladie d'Alzheimer utilisant des médicaments ciblant ces récepteurs. Ces médicaments pourraient être pris sous forme de comprimés, coûter moins cher et avoir moins d'effets secondaires que les traitements actuels à base d'anticorps.\n\n**Prochaine étape** – Les scientifiques vont développer des petites molécules pour activer SST1 et SST4 chez l'humain. Si cela fonctionne, cela pourrait mener à des médicaments plus sûrs, moins chers, qui aident à éliminer les plaques et protègent la mémoire.\n\n**Résumé en une phrase** – Activer deux récepteurs cérébraux pourrait renforcer la capacité naturelle du cerveau à éliminer les plaques d'Alzheimer, ouvrant la voie à de meilleurs traitements.",
      "personality_title_es": "Científicos descubren receptores cerebrales que eliminan placas de Alzheimer",
      "personality_presentation_es": "**Contexto** – La enfermedad de Alzheimer causa pérdida de memoria y está relacionada con grupos pegajosos de proteínas llamadas placas de beta-amiloide en el cerebro. Normalmente, una enzima llamada neprilisina ayuda a limpiar estas placas, pero funciona menos con la edad y la enfermedad.\n\n**Qué pasó** – Investigadores de Suecia y Japón encontraron dos receptores cerebrales, SST1 y SST4, que controlan los niveles de neprilisina en la parte del cerebro relacionada con la memoria. Al activar estos receptores en ratones, aumentaron la neprilisina, redujeron las placas y mejoraron la memoria, sin causar efectos secundarios graves.\n\n**Impacto** – Este hallazgo es importante porque señala una nueva forma de tratar el Alzheimer con medicamentos que pueden tomarse en pastillas, ser más baratos y causar menos efectos secundarios que los tratamientos actuales con anticuerpos.\n\n**Próximo paso** – Los científicos desarrollarán medicamentos pequeños que activen SST1 y SST4 en humanos. Si tiene éxito, esto podría llevar a tratamientos más seguros y accesibles que ayuden a eliminar las placas y proteger la memoria.\n\n**Resumen en una frase** – Activar dos receptores cerebrales podría mejorar la capacidad natural del cerebro para eliminar placas de Alzheimer, abriendo camino a mejores tratamientos.",
      "image_url": "public/images/news_image_Scientists-discover-brain-switches-that-clear-Alzh.png",
      "image_prompt": "A detailed, warm-toned painting of a glowing, stylized brain with two gently illuminated, interconnected receptor-shaped keys unlocking a delicate, intricate network of clearing pathways that dissolve soft, plaque-like clusters, all set against a calm, natural background of flowing, organic shapes symbolizing memory and healing."
    },
    {
      "title": "Nearly 200,000 people reveal the real key to heart health",
      "summary": "A decades-long study of nearly 200,000 adults challenges the low-carb versus low-fat debate. Both eating patterns were tied to lower heart disease risk when they emphasized whole grains, plant-based foods, and healthy fats. Versions filled with refined carbs and animal fats increased risk instead. Quality, not just quantity, appears to make the difference.",
      "content": "A new study published in JACC, the flagship journal of the American College of Cardiology, suggests that the type of foods people choose on a low-carbohydrate or low-fat diet may be more important than simply cutting carbs or fat. Researchers found that when these diets focused on nutrient-dense, wholesome foods, they were linked to a lower risk of coronary heart disease (CHD). In contrast, versions built around refined carbohydrates and animal products were associated with higher CHD risk and less favorable metabolic health markers.\n\nLow-carbohydrate and low-fat eating plans are common in the United States. However, scientists have not fully understood their long-term effects on heart health, especially when considering the quality of foods included in each pattern. This research stands out as one of the largest and most detailed investigations to date, examining diet quality, metabolomic data, and CHD risk in nearly 200,000 U.S. adults followed for more than 30 years.\n\nWhy Food Sources Matter in Low Carb and Low Fat Diets\n\n\"Our findings highlighted that it's not simply about cutting carbs or fat, but it's about the quality of foods people choose to construct those diets,\" said Zhiyuan Wu, a postdoctoral research fellow at the Harvard T.H. Chan School of Public Health and lead author of the study. \"The efficacy of low-carb and low-fat diets in reducing CHD risk is a topic of ongoing debate, and past studies showed mixed findings.\"\n\nWu noted that earlier research may have produced conflicting results because people can follow a low-carb or low-fat diet in very different ways. Some prioritize vegetables, whole grains, and healthy fats, while others rely more heavily on refined grains, processed foods, and animal-based fats.\n\n\"Focusing only on nutrient compositions but not food quality may not lead to health benefits,\" he said.\n\nLarge Long Term Study of Nearly 200,000 Adults\n\nTo better understand these differences, researchers analyzed data from 198,473 participants enrolled in three major cohort studies: the Nurses' Health Study (NHS), NHSII and Health Professionals Follow-up Study. Together, participants were tracked for more than 5.2 million person-years, during which 20,033 cases of CHD were recorded.\n\nDietary habits were measured using food frequency questionnaires. The research team then developed scoring systems to separate healthier and less healthy versions of low-carbohydrate and low-fat diets, based on the types of foods consumed and overall nutrient quality.\n\nHealthy vs Unhealthy Diet Patterns\n\nThe analysis revealed several important patterns:\n\nHealthy versions of both low-carb and low-fat diets that emphasized plant-based foods, whole grains and unsaturated fats were associated with a significantly lower risk of CHD.\n\nUnhealthy versions that were high in refined carbohydrates and animal-based fats and proteins were linked to a greater risk of CHD.\n\nHigher-quality diets were also associated with lower triglyceride levels, higher HDL cholesterol and reduced inflammation.\n\nMetabolomic testing supported these findings, showing favorable biomarker patterns among people who followed healthier diet patterns.\n\n\"These results suggest that healthy low-carbohydrate and low-fat diets may share common biological pathways that improve cardiovascular health,\" Wu said. \"Focusing on overall diet quality may offer flexibility for individuals to choose eating patterns that align with their preferences while still supporting heart health.\"\n\nStudy Limitations and Broader Implications\n\nThe researchers cautioned that the findings may not apply to more extreme dietary approaches with very low carbohydrate or fat intake, such as ketogenic diets. The results should be interpreted within the ranges of macronutrient intake observed in the study. In addition, dietary information was self-reported, which can introduce measurement error. Because participants were health professionals with generally higher health awareness and better access to care, the findings may not fully represent the general population, although the biological mechanisms involved are unlikely to differ substantially.\n\n\"This study helps move the conversation beyond the long-standing debate over low-carbohydrate versus low-fat diets,\" said Harlan M. Krumholz, MD, Editor-in-Chief of JACC. \"The findings show that what matters most for heart health is the quality of the foods people eat. Whether a diet is lower in carbohydrates or fat, emphasizing plant-based foods, whole grains, and healthy fats is associated with better cardiovascular outcomes.\"",
      "url": "https://www.sciencedaily.com/releases/2026/02/260216084521.htm",
      "source": "Latest Science News -- ScienceDaily",
      "published": "2026-02-17",
      "sentiment_score": 0.85,
      "reasoning": "The article reports on a large, long-term scientific study involving nearly 200,000 adults that identifies the importance of food quality in reducing coronary heart disease risk. This finding has broad public health significance, offering actionable dietary guidance that can improve cardiovascular health for many people. The study is detailed and focused, providing clear evidence that emphasizes nutrient-dense, plant-based foods and healthy fats over refined carbs and animal fats, thus advancing understanding in diet and heart disease prevention.",
      "category": "Health",
      "personality_title": "Study of 200,000 adults shows food quality matters most for heart health",
      "personality_presentation": "**Context** – Many people choose low-carbohydrate or low-fat diets to protect their hearts, but scientists have debated which is better. Past studies gave mixed results because they didn’t always consider the quality of the foods eaten.\n\n**What happened** – Researchers studied nearly 200,000 adults over 30 years, tracking their diets and heart health. They found that both low-carb and low-fat diets can lower the risk of heart disease if they include whole grains, plant-based foods, and healthy fats. Diets high in refined carbs and animal fats increased heart disease risk instead.\n\n**Impact** – This study shows it’s not just about cutting carbs or fat, but choosing the right kinds of foods. Healthy versions of these diets improved cholesterol levels and reduced inflammation, important factors for heart health. It gives people flexibility to pick diets they like while still protecting their hearts.\n\n**What's next step** – Scientists will explore how these findings apply to other diets, like very low-carb ketogenic plans. Doctors and nutrition experts might also use this information to give clearer advice focused on food quality rather than just nutrients.\n\n**One-sentence takeaway** – Choosing whole grains, plants, and healthy fats matters more than just lowering carbs or fat when it comes to protecting your heart.\n",
      "personality_title_fr": "Une étude sur 200 000 adultes montre que la qualité des aliments compte le plus pour la santé du cœur",
      "personality_presentation_fr": "**Contexte** – Beaucoup de personnes choisissent des régimes pauvres en glucides ou en graisses pour protéger leur cœur, mais les scientifiques débattent encore du meilleur choix. Les études précédentes ont donné des résultats variés car elles ne prenaient pas toujours en compte la qualité des aliments consommés.\n\n**Ce qui s'est passé** – Des chercheurs ont suivi près de 200 000 adultes pendant 30 ans, en observant leurs habitudes alimentaires et leur santé cardiaque. Ils ont découvert que les régimes pauvres en glucides ou en graisses réduisent le risque de maladie cardiaque quand ils contiennent des céréales complètes, des aliments végétaux et des graisses saines. En revanche, les régimes riches en glucides raffinés et en graisses animales augmentent ce risque.\n\n**Impact** – Cette étude montre que ce n’est pas seulement réduire les glucides ou les graisses qui compte, mais choisir les bons aliments. Les versions saines de ces régimes améliorent le cholestérol et réduisent l’inflammation, deux éléments clés pour le cœur. Cela offre aux gens la liberté de choisir un régime qui leur plaît tout en protégeant leur cœur.\n\n**Prochaine étape** – Les scientifiques vont explorer si ces résultats s’appliquent à d’autres régimes, comme les régimes cétogènes très pauvres en glucides. Les médecins pourraient aussi utiliser ces données pour mieux conseiller en se concentrant sur la qualité des aliments plutôt que sur les seuls nutriments.\n\n**Résumé en une phrase** – Pour protéger votre cœur, choisir des céréales complètes, des plantes et des graisses saines est plus important que simplement réduire les glucides ou les graisses.\n",
      "personality_title_es": "Estudio con 200,000 adultos muestra que la calidad de los alimentos es clave para la salud del corazón",
      "personality_presentation_es": "**Contexto** – Muchas personas eligen dietas bajas en carbohidratos o grasas para cuidar su corazón, pero los científicos no están seguros de cuál es mejor. Estudios anteriores dieron resultados diferentes porque no siempre consideraron la calidad de los alimentos.\n\n**Qué pasó** – Investigadores estudiaron a casi 200,000 adultos durante 30 años, observando sus dietas y salud cardíaca. Descubrieron que tanto las dietas bajas en carbohidratos como en grasas reducen el riesgo de enfermedades del corazón si incluyen granos enteros, alimentos vegetales y grasas saludables. Las dietas con carbohidratos refinados y grasas animales aumentaron el riesgo.\n\n**Impacto** – Este estudio muestra que no solo importa reducir carbohidratos o grasas, sino elegir los alimentos correctos. Las versiones saludables de estas dietas mejoraron el colesterol y redujeron la inflamación, factores importantes para el corazón. Esto da a las personas la opción de elegir dietas que les gusten mientras cuidan su salud.\n\n**Próximo paso** – Los científicos estudiarán cómo aplicar estos resultados a otras dietas, como las cetogénicas muy bajas en carbohidratos. Los médicos también podrían usar esta información para dar consejos basados en la calidad de los alimentos y no solo en nutrientes.\n\n**Resumen en una frase** – Elegir granos enteros, plantas y grasas saludables importa más que solo reducir carbohidratos o grasas para cuidar el corazón.\n",
      "image_url": "public/images/news_image_Nearly-200000-people-reveal-the-real-key-to-heart-.png",
      "image_prompt": "A warm and inviting detailed painting of a balanced plate divided into two halves, one side filled with vibrant whole grains, colorful vegetables, and nuts symbolizing healthy low-carb and low-fat foods, and the other side showing muted, less vibrant refined grains and animal fats subtly fading away, set against a soft natural background that evokes heart health and longevity."
    },
    {
      "title": "The science influencers going viral on TikTok to fight misinformation",
      "summary": "Nature, Published online: 17 February 2026; doi:10.1038/d41586-026-00472-5Scientists and medical experts are countering climate denialism, vaccine scepticism and wellness pseudoscience on social media.",
      "content": "One of Simon Clark’s most popular TikTok videos begins with him playing the part of a clueless climate contrarian. Adopting the overconfident tone that is common among social-media influencers, he proclaims: “Renewables are a scam!”\n\nThe ‘PhD influencers’ logging lab life on TikTok and Instagram\n\nCut to the real Clark, who has a PhD in stratospheric dynamics and uses the handle @simonoxfphys, as he dismantles several myths about renewable energy using a deadpan style and a torrent of charts. The video, with almost 180,000 views, is an effort to fight misinformation by meeting people where they are, he says.\n\nClark started making YouTube videos more than 15 years ago as a master’s student in physics at the University of Oxford, UK. He wanted to help others learn about getting into elite universities and navigating the collegiate system. After he got his PhD from the University of Exeter, UK, he decided to make content creation a full-time career. “The natural thing in my field was talking about the climate crisis,” he says, “the physical causes behind it, the solutions we have to it, and increasingly at the moment, why we aren’t implementing those solutions.”\n\nClark is now also on Instagram, Facebook and the live-streaming service Twitch, where he leans on his scientific credentials to both communicate science and combat misinformation. He is one of many scientists and medical experts who are countering the flood of anti-science advice and rhetoric across social-media platforms.\n\nAccording to a 2025 report by the Reuters Institute in Oxford and the University of Oxford, 65% of people worldwide now consume video on social media1. Increasingly, many individuals, especially young people, get their news from these platforms. But a lot of that ‘news’ is created by anti-science influencers who build loyal followings, using their position as opinion leaders to promote climate denialism, conspiracy theories, vaccine scepticism, autism myths, sham treatments and other pseudoscience.\n\nA study last year, for example, analysed nearly 1,000 Instagram and TikTok posts about controversial medical screening tests. It found that the posts were overwhelmingly misleading — and that the people posting often had financial interests in the treatment2. Another study analysed the 100 most popular TikTok videos on attention deficit hyperactivity disorder and found more than half to be misleading3. Yet the videos collectively had more than 280 million views.\n\nTo counteract this deluge of bad information, Clark and other pro-science content creators are taking strategies straight out of the influencer playbook.\n\nBuilding audiences\n\nSocial scientist Louisa Ha at Bowling Green State University in Ohio says that content creators who intend to mislead use clear tactics: “They pretend to be authentic, trustworthy and knowledgeable,” she says. They blend facts with misinformation to make it hard to tell what is credible. “The best lie is one that mixes seemingly authoritative sources and some facts with false data and false arguments and appeals to people’s beliefs and fears,” says Ha.\n\nWhether a video provokes people to engage with it matters more than the video’s accuracy, or even whether people agree with it, says Clark. The longer people linger on a video and the more they comment, the more likely it is that lots of people will see it.\n\nCan giant surveys of scientists fight misinformation on COVID, climate change and more?\n\nEncouraging such engagement is a tactic that Clark uses. In 2020, he made a 40-minute YouTube video on the debate over nuclear power, focusing on why some people see it as the best low-carbon technology whereas others say the risk of catastrophe is too great. He knew that the topic would be controversial. “I imagine that no matter what I say, I’m about to piss a lot of people off,” he says in the video. And he was right: it has more than 500,000 views, and nearly 6,000 comments.\n\nComments tend to be highly valued by engagement algorithms. Some creators do simple things, such as wearing a shirt backwards, so that viewers will post a comment pointing it out, says Clark. “It’s stupid”, he says, “but it works, so I guess it’s not stupid.”\n\nMisinformation abounds in the health and wellness space. As a registered dietician, Megan Rossi was struck by how many of her patients took diet advice from blogs and other online content. Frustrated by the lack of good science information, she started her own gut-health focused Instagram account @theguthealthdoctor in 2015, featuring video explainers about topics such as bloating, fibre, exercise and sleep, as well as offering recipe suggestions. (She has also developed a food brand and started a company that sells live bacteria supplements.)\n\nRossi leans into her credibility as a research fellow in nutritional sciences at King’s College London, often referring to herself as a “gut specialist/dietician”. She says that she’s careful to give advice based only on peer-reviewed evidence, and she typically cites her sources. Commenters often say things such as “very helpful” and “great info”, and thank her for not engaging in fearmongering.\n\nThe advent of social media has created communities that can more easily connect across time and space, and so has introduced a new type of opinion leader, says Amelia Burke-Garcia, director of the Center for Health Communication Science at the University of Chicago in Illinois. What’s important, says Burke-Garcia, who has been working with influencers in the public-health space since 2008 (“although we didn’t call them influencers then”), is to support credible voices and evidence in these communities.\n\nHow to speak to a vaccine sceptic: research reveals what works\n\nIn a qualitative study published last year, Burke-Garcia, public-health researcher Amy Leader at Thomas Jefferson University in Philadelphia, Pennsylvania, and their colleagues asked ten influencers of colour who had children aged 9 to 14 to spread the word about vaccination against human papillomavirus4. The influencers, whom the researchers provided with a fact sheet, created emotionally charged posts that acknowledged parents’ fears and used storytelling to describe their personal journeys towards a vaccination decision. Surveys of people who follow these influencers, Burke-Garcia says, revealed that the followers were more likely to consider vaccinating their children after hearing from someone to whom they could relate.\n\nThis relatability can help content creators to grow a loyal following. UK creator Emanuel Wallace, better known as Big Manny (@big.manny1), says that relatability, as well as authenticity, have been fundamental to his work. In his efforts to make chemistry and other science topics fun and accessible to young people, he has gained more than two million TikTok followers — and has made videos on the platform with Prince William and with Stranger Things star Millie Bobby Brown.\n\nHis videos show him doing science demonstrations ranging from standard classroom ones — what happens when you burn magnesium — to those requiring sophisticated set-ups and equipment. One video shows a chicken breast being exposed to the insides of a lithium battery. “This chicken breast represents you,” he says, before it bursts into flames. It’s a powerful warning about the dangers of swallowing a lithium battery.\n\nHis expertise as a former secondary-school science technician comes through, even with his casual approach: “I don’t really look like a typical scientist. I don’t wear a lab coat. Sometimes I might have a tracksuit on. And I use colloquial terms in my speech,” he says. “I just be myself.”\n\nQuashing misinformation\n\nWhen it comes to fighting misinformation, content creators take various approaches. Clark favours “pre-bunking” rather than debunking, which he finds less effective. He tries to reach a broad audience with solid facts that leave no room for ambiguity: “This is like vaccinating them against misinformation”.\n\nOthers have gained a reputation for challenging misinformation head-on. Russian–American creator Mikhail Varshavski, better known online as Doctor Mike (@doctormike), spends half of his week as a family-medicine physician and the other half creating content for his 14.6 million YouTube, 5.3 million Instagram and 2.7 million TikTok followers. He aims his content not just at people who agree with him, but also at those who haven’t thought much about their health care, who have been hurt by the system or even who disagree with modern medicine.",
      "url": "https://www.nature.com/articles/d41586-026-00472-5",
      "source": "Nature",
      "published": "2026-02-18",
      "sentiment_score": 0.85,
      "reasoning": "The article highlights scientists and medical experts effectively using social media platforms to combat widespread misinformation on critical topics like climate change, vaccines, and health pseudoscience. This has a broad positive impact by promoting accurate science communication to large, diverse audiences, especially young people, thereby fostering informed decision-making and public health. The article provides detailed examples and context, demonstrating a meaningful and substantive effort to counteract misinformation at scale.",
      "category": "Health",
      "personality_title": "Scientists use TikTok and social media to fight false information",
      "personality_presentation": "**Context** – Many people, especially young ones, get news and information from social media platforms like TikTok and Instagram. However, a lot of this information is wrong or misleading, especially about important topics like climate change, vaccines, and health.\n\n**What happened** – Scientists and medical experts, such as Simon Clark and Megan Rossi, are creating videos and posts on social media to share true, science-based facts. They use engaging and clear ways to explain complicated topics and correct false ideas. For example, Simon Clark makes videos that break down myths about renewable energy, while Megan Rossi shares trustworthy advice about gut health.\n\n**Impact** – These experts are reaching millions of people who might otherwise see only false or confusing messages. By using the same tricks as popular social media influencers—like encouraging comments and being relatable—they make science easy to understand and trust. This helps people make better decisions about their health and the environment.\n\n**What's next step** – These scientists plan to keep growing their audiences and improving their content to reach even more people. Researchers also study how influencers can best share accurate information, especially on sensitive topics like vaccines, to help communities make informed choices.\n\n**One-sentence takeaway** – Scientists and health experts are successfully using social media to share real facts and stop false information from spreading online.\n",
      "personality_title_fr": "Des scientifiques utilisent TikTok et les réseaux sociaux pour combattre les fausses informations",
      "personality_presentation_fr": "**Contexte** – Beaucoup de personnes, surtout les jeunes, s’informent via les réseaux sociaux comme TikTok et Instagram. Mais beaucoup d’informations sur ces plateformes sont fausses ou trompeuses, notamment sur des sujets importants comme le changement climatique, les vaccins et la santé.\n\n**Ce qui s’est passé** – Des scientifiques et experts médicaux, comme Simon Clark et Megan Rossi, créent des vidéos et publications sur les réseaux sociaux pour partager des faits vrais et basés sur la science. Ils expliquent des sujets compliqués de manière claire et attirante, et corrigent les idées fausses. Par exemple, Simon Clark démonte les mythes sur les énergies renouvelables, et Megan Rossi donne des conseils fiables sur la santé intestinale.\n\n**Impact** – Ces experts atteignent des millions de personnes qui verraient autrement seulement de fausses informations. En utilisant les mêmes méthodes que les influenceurs populaires — encourager les commentaires et être accessibles — ils rendent la science facile à comprendre et digne de confiance. Cela aide les gens à prendre de meilleures décisions pour leur santé et l’environnement.\n\n**Prochaine étape** – Ces scientifiques veulent continuer à augmenter leur audience et améliorer leurs contenus pour toucher encore plus de monde. Des chercheurs étudient aussi comment les influenceurs peuvent mieux partager des informations précises, notamment sur des sujets sensibles comme les vaccins, pour aider les communautés.\n\n**Résumé en une phrase** – Des scientifiques et experts en santé utilisent avec succès les réseaux sociaux pour diffuser des faits réels et arrêter la propagation de fausses informations.\n",
      "personality_title_es": "Científicos usan TikTok y redes sociales para combatir la desinformación",
      "personality_presentation_es": "**Contexto** – Muchas personas, especialmente jóvenes, obtienen noticias e información en redes sociales como TikTok e Instagram. Sin embargo, mucha de esta información es falsa o engañosa, especialmente sobre temas importantes como el cambio climático, las vacunas y la salud.\n\n**Qué pasó** – Científicos y expertos médicos, como Simon Clark y Megan Rossi, están creando videos y publicaciones en redes sociales para compartir hechos verdaderos basados en la ciencia. Usan formas claras y atractivas para explicar temas difíciles y corregir ideas falsas. Por ejemplo, Simon Clark desmonta mitos sobre energías renovables, y Megan Rossi ofrece consejos confiables sobre la salud intestinal.\n\n**Impacto** – Estos expertos llegan a millones de personas que de otra manera solo verían información falsa o confusa. Usando las mismas estrategias que los influencers populares —como fomentar comentarios y ser cercanos— hacen que la ciencia sea fácil de entender y confiar. Esto ayuda a las personas a tomar mejores decisiones sobre su salud y el medio ambiente.\n\n**Próximo paso** – Estos científicos planean seguir creciendo su audiencia y mejorar su contenido para alcanzar a más personas. Investigadores también estudian cómo los influencers pueden compartir mejor información correcta, especialmente sobre temas sensibles como las vacunas, para ayudar a las comunidades.\n\n**Frase clave** – Científicos y expertos en salud están usando con éxito las redes sociales para compartir hechos reales y detener la difusión de información falsa.\n",
      "image_url": "public/images/news_image_The-science-influencers-going-viral-on-TikTok-to-f.png",
      "image_prompt": "A warm, detailed painting of a glowing vintage-style lantern illuminating an open book filled with scientific charts and data, surrounded by a diverse group of shadowy silhouettes attentively gathered in a circle, symbolizing the spread of trustworthy knowledge and the fight against misinformation through engaging, relatable science communication."
    }
  ]
}